A2, AgResearch win $1.15m government research grant
AgResearch’s Matthew Barnett, who will lead the research with A2 Milk’s chief scientific officer Andrew Clarke, says they believe there are some variants in milk proteins that some people, particularly Asians, don’t tolerate very well, based on preliminary research.
“What we’ve found is that A2 milk does behave differently from some other milks in terms of intestinal function and particularly, it seems to either avoid or reduce the possibility of intestinal inflammation,” Mr Barnett says.
“We’ve worked closely with the A2 Milk company for a while now, on and off, and they’ve done some of their own research which they thought was promising,” he says.
“Essentially, some people avoid diary and some of them do that because they believe they’re lactose intolerant. What we think is that’s true for some people but for other people it may not be and A2 might enable more people to drink milk than otherwise do,” he says.
“So, a great business opportunity for A2 if they can show that.”
Mr Barnett says the plan is to run a pilot study involving 12 people initially and then to do a larger study involving about 40 people.
The study also involves the University of Auckland.
- Forums
- ASX - By Stock
- A2M
- A2, AgResearch win $1.15m government research grant
A2, AgResearch win $1.15m government research grant
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.82 |
Change
-0.100(2.03%) |
Mkt cap ! $3.489B |
Open | High | Low | Value | Volume |
$4.95 | $4.95 | $4.77 | $31.51M | 6.542M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 56040 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.82 | 252136 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 5.290 |
1 | 48 | 5.090 |
8 | 83771 | 5.060 |
5 | 454022 | 5.050 |
1 | 388 | 5.020 |
Price($) | Vol. | No. |
---|---|---|
4.390 | 145498 | 15 |
4.560 | 65759 | 10 |
4.570 | 30447 | 12 |
4.630 | 12226 | 1 |
4.640 | 17722 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online